Shen, G., Liu, Z., Wang, M., Zhao, Y., Liu, X., Hou, Y., . . . Zhao, J. Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: The phase 2 NeoSAC trial. Nature Publishing Group.
Chicago Style (17th ed.) CitationShen, Guoshuang, et al. Neoadjuvant Apatinib Addition to Sintilimab and Carboplatin-taxane Based Chemotherapy in Patients with Early Triple-negative Breast Cancer: The Phase 2 NeoSAC Trial. Nature Publishing Group.
MLA (9th ed.) CitationShen, Guoshuang, et al. Neoadjuvant Apatinib Addition to Sintilimab and Carboplatin-taxane Based Chemotherapy in Patients with Early Triple-negative Breast Cancer: The Phase 2 NeoSAC Trial. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.